Toxicological effects of the Morinda citrifolia L. fruit extract on maternal reproduction and fetal development in rats.

Morinda citrifolia L., also known as Noni, is widely used plant in folk medicine for various therapeutic purposes. However, reports on its effects during pregnancy are limited. Therefore, the objective of this study was to evaluate the effects of the M. citrifolia fruit extract on maternal performance and fetal development during pregnancy in rats. Pregnant Wistar rats (n = 12/group) were treated from gestational days (GD) 0-21 with water (control group) or the aqueous extract of M. citrifolia fruit at doses of 200, 400, or 750 mg/kg, orally. During pregnancy, clinical signs of toxicity, maternal weight, feed intake, and water consumption were noted. On GD 21, the rats were anesthetized and blood was collected to evaluate various biochemical parameters. During laparotomy, reproductive performance parameters were recorded, and fetuses were weighed and the anomalies analyzed. Reduced placental efficiency and fetal growth restriction were observed in the group treated with 400 mg/kg of M. citrifolia extract. The highest dose (750 mg/kg) augmented aspartate aminotransferase concentration and preimplantation losses, while reducing the number of live fetuses. Furthermore, both doses (400 and 750 mg/kg) of the plant extract caused fetal anomalies. In conclusion, consumption of high doses of the M. citrifolia aqueous extrac during pregnancy leads to maternal hepatotoxicity, anti-implantation effects, intrauterine growth restriction and fetal abnormalities, indicating that the plant fruit extract can be harmful to both the mother and the fetus.

Genotoxicity, acute and subchronic toxicity evaluation of fermented Morinda officinalis.

Morinda officinalis has diverse pharmacological effects and has the potential to be used as functional food and medicine. Fermentation is traditionally used to process Morinda officinalis. However, the toxicological profile of fermented Morinda officinalis (FMO) is not reported. In the present study, the toxicological characteristics of FMO were assessed for the first time. FMO did not show any genotoxicity based on the Ames test, mammalian erythrocyte micronucleus test, and mouse primary spermatocyte chromosome aberration test. FMO administered by gavage in mice and rats at a dose of 20 g/kg BW did not induce death or toxicity based on acute study, indicating that FMO could be regarded as non-toxic at the tested dose. In the 90-day subchronic toxicity study, rats fed with FMO at the maximum dose of 8 g/kg BW did not affect mortalities, BW, food consumption, organ weights, hematology, serum biochemistry, or urinalysis. The no observed adverse effect level of FMO in both sexes was not less than 8 g/kg BW/day based on subchronic toxicity. The obtained results support the safe use of FMO as functional food and medicine.

Avaliação citotóxica, genotóxica e mutagênica do extrato de Morinda citrifolia em diferentes concentrações sobre o teste Allium Cepa / Cytotoxic, genotoxic and mutagenic evaluation of Morinda citrifolia extract in different concentrations about the test Allium Cepa

Introdução: o uso de Morinda citrifolia (noni) realizado com várias finalidades, no entanto, sua eficácia ainda não é, plenamente, comprovada. Segundo a Agência Nacional de Vigilância Sanitária (2007), as publicações científicas sobre o suco de noni têm trazido muita controvérsia sobre sua segurança como alimento. Objetivos: o objetivo do presente trabalho foi avaliar quais concentrações de Morinda citrifolia não apresentam efeitos citotóxicos, genotóxicos e mutagênicos, possibilitando seu uso em futuras formas farmacêuticas. Metodologia: os frutos foram picados e desidratados em estufa. Em seguida o material foi pulverizado, obtendo-se o extrato seco. Foram utilizados bulbos de Alium cepa para testar as seguintes concentrações: controle negativo (água filtrada), 1 mg/mL (Tratamento 1), 1,5 mg/mL (Tratamento 2), 2 mg/mL (Tratamento 3), controle positivo (paracetamol 90 mg/mL). Resultados: os resultados encontrados na análise dos dados do extrato aquoso, demonstram que as três concentrações testadas de Morinda citrifolia apresenta atividade tóxica pela inibição do comprimento e pela diminuição do ciclo celular das raízes. Além disso, a Morinda citrifolia apresenta atividade citotóxica, devido à redução do índice mitótico, em todas as concentrações analisadas. Bem como, apresenta atividade genotóxica, nas duas maiores concentrações do extrato (1,5 mg/mL e 2,0 mg/mL). Conclusão: o presente estudo demonstrou que os extratos de Morinda citrifolia apresenta atividade citotóxica e genotóxica em todas as concentrações analisadas. É necessário realizar outros trabalhos para a avaliação da Morinda citrifolia em concentrações menores, para assim se estabelecer quais são as concentrações seguras de utilização do suco desse fruto

Morinda officinalis How. - A comprehensive review of traditional uses, phytochemistry and pharmacology.

ETHNOPHARMACOLOGICAL RELEVANCE: The medicinal plant Morinda officinalisHow. (MO) and its root have long been used in traditional medicines in China and northeast Asia as tonics for nourishing the kidney, strengthening the bone and enhancing immunofunction in the treatment of impotence, osteoporosis, depression and inflammatory diseases such as rheumatoid arthritis and dermatitis. AIM OF THE REVIEW: This review aims to sum up updated and comprehensive information about traditional usage, phytochemistry, pharmacology and toxicology of MO and provide insights into potential opportunities for future research and development of this plant. METHODS: A bibliographic investigation was performed by analyzing the information available on MO in the internationally accepted scientific databases including Pubmed, Scopus and Web of Science, SciFinder, Google Scholar, Yahoo, Ph.D. and M.Sc. dissertations in Chinese. Information was also obtained from some local and foreign books on ethnobotany and ethnomedicines. RESULTS: The literature supported the ethnomedicinal uses of MO as recorded in China for various purposes. The ethnomedical uses of MO have been recorded in many regions of China. More than 100 chemical compounds have been isolated from this plant, and the major constituents have been found to be polysaccharides, oligosaccharides, anthraquinones and iridoid glycosides. Crude extracts and pure compounds of this plant are used as effective agents in the treatment of depression, osteoporosis, fatigue, rheumatoid arthritis, and infertility due to their anti-depressant, anti-osteoporosis, pro-fertility, anti-radiation, anti-Alzheimer disease, anti-rheumatoid, anti-fatigue, anti-aging, cardiovascularprotective, anti-oxidation, immune-regulatory, and anti-inflammatory activities. Pharmacokinetic studies have demonstrated that the main components of MO including monotropein and deacetyl asperulosidic acid are distributed in various organs and tissues. The investigation on acute toxicity and genotoxicity indicated that MO is nontoxic. There have no reports on significant adverse effect at a normal dose in clinical application, but MO at dose of more than 1000mg/kg may cause irritability, insomnia and unpleasant sensations in individual cases. CONCLUSION: MO has emerged as a good source of traditional medicines. Some uses of this plant in traditional medicines have been validated by pharmacological investigations. However, the molecular mechanism, structure-activity relationship, and potential synergistic and antagonistic effects of its multi-components such as polysaccharides, oligosaccharides, anthraquinones and iridoid glycosides need to be further elucidated, and the structural feature of polysaccharides also need to be further clarified. Sophisticated analytical technologies should be developed to comprehensively evaluate the quality of MO based on HPLC-fingerprint and content determination of the active constituents, knowing that these investigations will help further utilize this plant.

Assessment of the cytotoxicity and genotoxicity properties of Uvaria chamae P. Beauv (Annonaceae) and Morinda lucida Benth (Rubiaceae) in mice.

The toxicity profile of medicinal plants is an important preclinical requirement in the development of phytomedicines. The cytotoxic and genotoxic effects of the leaf of Uvaria chamae P. Beauv (Annonaceae) and stem bark of Morinda lucida Benth (Rubiaceae) were investigated in order to provide information on their safety as antimalarial plants. The methanol extract of U. chamae and ethanol (70%) extract of M. lucida were separately orally administered (125, 250, and 750 mg/kg/day) to mice for 10 consecutive days. Cyclophosphamide (50 mg/kg, single dose) and distilled water were used as positive and negative controls, respectively. The mice were injected with colchicine (0.04%) intra-peritoneally 24 h after the last administration of the extracts and the bone marrows harvested. Giemsa-stained slides of bone marrow cells were microscopically assessed for dividing cells to determine the mitotic index (MI) and scored for chromosomal aberrations (CA) according to standard methods. chamae exhibited dose-dependent cytotoxicity. At 750 mg/kg, the MI was significantly (p < 0.05) lower (1.81 ± 0.04) than that of cyclophosphamide (5.83 ± 0.04). The lower the MI, the higher the cytotoxicity. The activity of M. lucida was not significantly different (p > 0.05) from that of the negative control. The total CA observed from treatment with both plants at all doses were significantly (p < 0.05) greater than that of control. This study concluded that U. chamae showed both cytotoxicity and genotoxicity while M. lucida exerted only genotoxic effect. Nevertheless, the two plants should be used with caution in antimalarial therapy.

Toxicidad oral aguda de los extractos etanólicos de Eucalyptus globulus, Morinda citrifolia, Peperomia glauca, Schinus molle y Zea mays en ratones BALB/c 53 / Acute oral toxicity of Eucalyptus globulus, Morinda citrifolia, Peperomia glauca, Schinus molle and Zea mays ethanolic extracts on BALB/c 53 mice

Objetivo. Evaluar la toxicidad aguda de los extractos etanólicos del Eucalyptus globulus Labill. (eucalipto), Morinda citrifolia L. (noni), Peperomia glauca (pino) (congona), Schinus molle L. (molle) y Zea mays L. (Maíz morado) en ratones Balb/c 53. Materiales y métodos. Se utilizaron 60 ratones machos divididos en seis grupos (eucalipto, noni, congona, molle, maíz morado y control). Los grupos tratados recibieron por vía oral una dosis única de 2000 mg/kg de los extractos etanólicos, y el grupo control recibió polisorbato 2 mL/kg al 3%. Se evaluó ganancia de peso, valores hematológicos (hematocrito, eritrocitos, hemograma, leucocitos, plaquetas), bioquímica sérica (úrea, creatinina, ALT, proteínas totales, albumina, globulinas), histopatología hepática y renal. Resultados. Se observó signos de inquietud, excitación y aparente fotosensibilidad en el grupo eucalipto, por una hora. Se encontró leucopenia en grupos congona, molle, eucalipto y maíz morado; trombocitopenia en grupos eucalipto y molle, y elevación del ALT en los grupos congona y eucalipto, en comparación con los valores del grupo control. La ganancia de peso, los demás valores hematológicos, así como la bioquímica renal y hepática en los otros grupos no fueron significativos. Conclusiones. En las condiciones experimentales no se observó signos de toxicidad ni mortalidad en el ensayo; la DL50 de los extractos etanólicos estaría sobre los 2000 mg/kg.

Objective. This study was performed to evaluate the acute toxicity of ethanolic extracts of Eucalyptus globulus Labill. (Eucalipto), Morinda citrifolia L. (noni), Peperomia glauca (pino) (Congona), Schinus molle L. (molle) y Zea mays L. (maíz morado) in Balb/c mice. Materials and methods. Sixty male mice were divided into 6 groups (Eucalipto, Noni, Congona, Molle, Maíz morado and Control) of 10 each were used. The guide for the Organization for Economic Cooperation and Development (OECD 423) was followed for the study. The treated group received for gavage a single dose at 2000 mg/kg and the control group received polysorbate at 2 mL/kg at 3%. Weight gain, hematological values (hematocrit, erythrocytes, hemogram, leukocytes, platelets), serum biochemistry (urea, creatinine, ALT, total proteins, albumin, globulins), hepatic and renal histopathology were performed. Results. No signs of mortality and morbidity were observed as a consequence of the administration of the extracts, except for the Eucalipto group, which presented restlessness, excitation and apparent photosensitivity for one hour. There was leukopenia in Congona, Molle, Eucalipto and Maíz morado groups; thrombocytopenia in groups Eucalipto and Molle; and elevations of ALT in Congona and Eucalipto groups in comparison than the values from control group. Weight gain and other hematological values, as well as renal and hepatic biochemistry in the other groups were not significant. Conclusions. Under experimental conditions no signs of toxicity or mortality were observed in the trial; the LD50 of the ethanolic extracts would be above 2000 mg/kg.

Transcriptomic Analysis of Octanoic Acid Response in Drosophila sechellia Using RNA-Sequencing.

The dietary specialist fruit fly Drosophila sechellia has evolved to specialize on the toxic fruit of its host plant Morinda citrifolia Toxicity of Morinda fruit is primarily due to high levels of octanoic acid (OA). Using RNA interference (RNAi), prior work found that knockdown of Osiris family genes Osiris 6 (Osi6), Osi7, and Osi8 led to increased susceptibility to OA in adult D. melanogaster flies, likely representing genes underlying a Quantitative Trait Locus (QTL) for OA resistance in D. sechellia While genes in this major effect locus are beginning to be revealed, prior work has shown at least five regions of the genome contribute to OA resistance. Here, we identify new candidate OA resistance genes by performing differential gene expression analysis using RNA-sequencing (RNA-seq) on control and OA-exposed D. sechellia flies. We found 104 significantly differentially expressed genes with annotated orthologs in D. melanogaster, including six Osiris gene family members, consistent with previous functional studies and gene expression analyses. Gene ontology (GO) term enrichment showed significant enrichment for cuticle development in upregulated genes and significant enrichment of immune and defense responses in downregulated genes, suggesting important aspects of the physiology of D. sechellia that may play a role in OA resistance. In addition, we identified five candidate OA resistance genes that potentially underlie QTL peaks outside of the major effect region, representing promising new candidate genes for future functional studies.

Chronic toxicity evaluation of Morinda citrifolia fruit and leaf in mice.

Noni (Morinda citrifolia) leaf and fruit are used as food and medicine. This report compares the chronic toxicity of Noni fruit and edible leaf water extracts (two doses each) in female mice. The 6 months study showed the fruit extract produced chronic toxicity effects at the high dose of 2 mg/ml drinking water, evidenced through deteriorated liver histology (hepatocyte necrosis), reduced liver length, increased liver injury marker AST (aspartate aminotransferase) and albumin reduction, injury symptoms (hypoactivity, excessive grooming, sunken eyes and hunched posture) and 40% mortality within 3 months. This hepatotoxicity results support the six liver injury reports in humans which were linked to chronic noni fruit juice consumption. Both doses of the leaf extracts demonstrated no observable toxicity. The hepatotoxicity effects of the M. citrifolia fruit extract in this study is unknown and may probably be due to the anthraquinones in the seeds and skin, which had potent quinone reductase inducer activity that reportedly was 40 times more effective than l-sulforaphane. This report will add to current data on the chronic toxicity cases of Morinda citrifolia fruit. No report on the chronic toxicity of Morinda citrifolia fruit in animal model is available for comparison.

Morinda citrifolia: fatos e riscos sobre o uso do noni / Morinda citrifolia: Facts and Risks About the use of noni

Morinda citrifolia L. (Rubiaceae), popularmente conhecida como noni, é amplamente utilizada na Polinésia e no Havaí, para tratamento de diversas patologias, como: dislipidemia, diabetes, câncer, hipertensão, cicatrização, dentre outras. Atualmente, observa-se também o uso exacerbado no Brasil, especialmente na região Nordeste, onde a planta se adaptou bem. Porém, ainda não há certeza da sua eficácia, e muitas pesquisas sobre a ação terapêutica do noni estão em desenvolvimento, embora os resultados sejam bastante controversos. O que torna o noni uma planta diferenciada e que requer atenção especial é seu potencial hepatotóxico. A Agência Nacional de Vigilância Sanitária (ANVISA) fundamenta a sua recomendação de não utilizar o noni, também, com base em relatos de toxicidade em humanos. Este trabalho é uma revisão da literatura, com objetivo de avaliar o potencial terapêutico desta planta de acordo com os estudos já desenvolvidos. Dessa forma, é possível realizar uma análise crítica do uso irracional desta planta e contribuir com a divulgação de possíveis riscos à saúde.(AU)

Morinda citrifolia L. (Rubiaceae), noni, is used in Polynesia and Hawaii in folk medicine against several pathologies. Nowadays it is in process an irrational and dangerous use by Brazilians, especially in Northeastern, since this species is easily cultivated in our climate. The evaluable scientific evidences are not enough to guarantee the noni effectiveness and security. The point is the hepatotoxic potential by noni use. The Brazilian sanitary authorities recommend that the population should not use noni founded on some reported hepatotoxic cases. This paper aims to compile information about chemical, pharmacological and toxicological aspects regarding noni scientific data to contribute to the knowledge about the possible risks to health.(AU)

Recurrent specialization on a toxic fruit in an island Drosophila population.

Recurrent specialization on similar host plants offers a unique opportunity to unravel the evolutionary and genetic mechanisms underlying dietary shifts. Recent studies have focused on ecological races belonging to the same species, but it is hard in many cases to untangle the role of adaptive introgression versus distinct mutations in facilitating recurrent evolution. We discovered on the island of Mayotte a population of the generalist fly Drosophila yakuba that is strictly associated with noni (Morinda citrifolia). This case strongly resembles Drosophila sechellia, a genetically isolated insular relative of D. yakuba whose intensely studied specialization on toxic noni fruits has always been considered a unique event in insect evolution. Experiments revealed that unlike mainland D. yakuba strains, Mayotte flies showed strong olfactory attraction and significant toxin tolerance to noni. Island females strongly discriminated against mainland males, suggesting that dietary adaptation has been accompanied by partial reproductive isolation. Population genomic analysis indicated a recent colonization (∼29 kya), at a time when year-round noni fruits may have presented a predictable resource on the small island, with ongoing migration after colonization. This relatively recent time scale allowed us to search for putatively adaptive loci based on genetic variation. Strong signals of genetic differentiation were found for several detoxification genes, including a major toxin tolerance locus in D. sechellia Our results suggest that recurrent evolution on a toxic resource can involve similar historical events and common genetic bases, and they establish an important genetic system for the study of early stages of ecological specialization and speciation.

A locus in Drosophila sechellia affecting tolerance of a host plant toxin.

Many insects feed on only one or a few types of host. These host specialists often evolve a preference for chemical cues emanating from their host and develop mechanisms for circumventing their host's defenses. Adaptations like these are central to evolutionary biology, yet our understanding of their genetics remains incomplete. Drosophila sechellia, an emerging model for the genetics of host specialization, is an island endemic that has adapted to chemical toxins present in the fruit of its host plant, Morinda citrifolia. Its sibling species, D. simulans, and many other Drosophila species do not tolerate these toxins and avoid the fruit. Earlier work found a region with a strong effect on tolerance to the major toxin, octanoic acid, on chromosome arm 3R. Using a novel assay, we narrowed this region to a small span near the centromere containing 18 genes, including three odorant binding proteins. It has been hypothesized that the evolution of host specialization is facilitated by genetic linkage between alleles contributing to host preference and alleles contributing to host usage, such as tolerance to secondary compounds. We tested this hypothesis by measuring the effect of this tolerance locus on host preference behavior. Our data were inconsistent with the linkage hypothesis, as flies bearing this tolerance region showed no increase in preference for media containing M. citrifolia toxins, which D. sechellia prefers. Thus, in contrast to some models for host preference, preference and tolerance are not tightly linked at this locus nor is increased tolerance per se sufficient to change preference. Our data are consistent with the previously proposed model that the evolution of D. sechellia as a M. citrifolia specialist occurred through a stepwise loss of aversion and gain of tolerance to M. citrifolia's toxins.

[Hepatoxic effect of a noni juice consumption--a case report]. / Hepatoksyczny efekt spozywania soku noni--opis przypadku.

UNLABELLED: Noni juice of an Indian mulberry fruit has recently become a very popular remedy for several diseases. The paper presents the case of hepatotoxic action of Noni juice in a previously healthy 55-years old female patient. After symptomatic therapy and cessation of exposure to the juice all symptoms dissapeared. CONCLUSIONS: 1. Indian mulberry formulations may, in some cases, lead to liver toxicity. 2. Treatment consists of cessation of exposure to preparations containing Indian mulberry fruits and a symptomatic therapy. 3 There is an urgent need to examine the therapeutic and toxic effects of commonly used herbal specifics.

Actividad antimicrobiana y toxicidad frente a Artemia salina del extracto diclorometánico de raíces de Morinda royoc L / Antimicrobial action and toxicity against Artemia salina of the dichlormethane extract from Morinda royoc L roots

Introducción: las plantas son una fuente de diversidad natural por la gran variedad de compuestos que sintetizan. Particularmente las antraquinonas resultan un importante grupo de metabolitos secundarios con actividad antimicrobiana y antioxidante. Objetivos: evaluar la actividad antimicrobiana del extracto diclorometánico de raíces de Morinda royoc L, así como su toxicidad contra Artemia salina. Métodos: la actividad antimicrobiana se determinó utilizando el método de microdilución en placa de 96 pozos. Se evaluó la actividad del extracto frente a 7 aislados clínicos de Candida spp. y frente a las bacterias Staphylococcus aureus resistente a meticilina, Staphylococcus aureus ATCC 12598, Enterococus faecales, Escherichia coli, Acinetobacter baumanii, Pseudomonas aeruginosa y Klebsiella pneumoniae. La toxicidad del extracto se evaluó mediante el ensayo de letalidad con A salina. Resultados: el extracto crudo fue activo frente a todas las especies de Candida evaluadas. La concentración mínima inhibitoria más baja fue 1,95 µg/mL. El extracto mostró fuerte actividad inhibitoria contra S. aureus, E faecales, y E coli. El valor más bajo de concentración mínima inhibitoria obtenido fue 31,25 µg/mL. El extracto presentó una toxicidad moderada hacia A salina. Conclusiones: los resultados obtenidos demuestran el potencial del extracto diclorometánico de raíces de M. royoc L en el tratamiento de infecciones causadas por bacterias y hongos

Introduction: plants are a source of natural diversity because of the great variety of compounds that they synthesize. Anthraquinones in particular are an important group of secondary metabolites characterized by their antimicrobial and antioxidant action. Objectives: to evaluate the antimicrobial action of dichloromethane extract from Morinda royoc L roots as well as its toxicity against Artemia salina. Methods: the antimicrobial action was determined by using the brooth microdilution in 96-well plate. The extract action against 7 Candida spp clinical isolates and against bacteria such as methicillin-resistant Staphylococcus aureus, Staphylococcus aureus ATCC 12598, Enterococus faecales, Escherichia coli, Acinetobacter baumanii, Pseudomonas aeruginosa and Klebsiella pneumoniae was evaluated. The extract toxicity was measured using brine shrimp (Artemia salina) lethality test. Results: the crude extract proved to be active against all the tested Candida species. The lowest minimal inhibitory concentration was 1,95 µg/mL. The extract showed strong inhibitory action against S aureus, E. faecales, and E coli. The lowest minimal inhibitory concentration was 31.25 µg/mL. The extract presented moderate toxicity against A salina. Conclusions: the results showed the potentialities of dichloromethane extract from M. royoc L. roots for the treatment of bacterial and fungal infections

Actividad antimicrobiana y toxicidad frente a Artemia salina del extracto diclorometánico de raíces de Morinda royoc L / Antimicrobial action and toxicity against Artemia salina of the dichlormethane extract from Morinda royoc L roots

Introducción: las plantas son una fuente de diversidad natural por la gran variedad de compuestos que sintetizan. Particularmente las antraquinonas resultan un importante grupo de metabolitos secundarios con actividad antimicrobiana y antioxidante. Objetivos: evaluar la actividad antimicrobiana del extracto diclorometánico de raíces de Morinda royoc L, así como su toxicidad contra Artemia salina. Métodos: la actividad antimicrobiana se determinó utilizando el método de microdilución en placa de 96 pozos. Se evaluó la actividad del extracto frente a 7 aislados clínicos de Candida spp. y frente a las bacterias Staphylococcus aureus resistente a meticilina, Staphylococcus aureus ATCC 12598, Enterococus faecales, Escherichia coli, Acinetobacter baumanii, Pseudomonas aeruginosa y Klebsiella pneumoniae. La toxicidad del extracto se evaluó mediante el ensayo de letalidad con A salina. Resultados: el extracto crudo fue activo frente a todas las especies de Candida evaluadas. La concentración mínima inhibitoria más baja fue 1,95 µg/mL. El extracto mostró fuerte actividad inhibitoria contra S. aureus, E faecales, y E coli. El valor más bajo de concentración mínima inhibitoria obtenido fue 31,25 µg/mL. El extracto presentó una toxicidad moderada hacia A salina. Conclusiones: los resultados obtenidos demuestran el potencial del extracto diclorometánico de raíces de M. royoc L en el tratamiento de infecciones causadas por bacterias y hongos(AU)

Introduction: plants are a source of natural diversity because of the great variety of compounds that they synthesize. Anthraquinones in particular are an important group of secondary metabolites characterized by their antimicrobial and antioxidant action. Objectives: to evaluate the antimicrobial action of dichloromethane extract from Morinda royoc L roots as well as its toxicity against Artemia salina. Methods: the antimicrobial action was determined by using the brooth microdilution in 96-well plate. The extract action against 7 Candida spp clinical isolates and against bacteria such as methicillin-resistant Staphylococcus aureus, Staphylococcus aureus ATCC 12598, Enterococus faecales, Escherichia coli, Acinetobacter baumanii, Pseudomonas aeruginosa and Klebsiella pneumoniae was evaluated. The extract toxicity was measured using brine shrimp (Artemia salina) lethality test. Results: the crude extract proved to be active against all the tested Candida species. The lowest minimal inhibitory concentration was 1,95 µg/mL. The extract showed strong inhibitory action against S aureus, E. faecales, and E coli. The lowest minimal inhibitory concentration was 31.25 µg/mL. The extract presented moderate toxicity against A salina. Conclusions: the results showed the potentialities of dichloromethane extract from M. royoc L. roots for the treatment of bacterial and fungal infections(AU)

Clasificación toxicológica aguda del fruto seco pulverizado de Morinda citrifolia L (NONI-C)® en ratas Cenp: SPRD / Acute toxicity classification of powdered dry fruit of Morinda citrifolia L. (NONI-C)® in Cenp:SPRD rats

INTRODUCCIÓN: Morinda citrifolia L. se ha usado en la medicina tradicional para reducir dolores crónicos, regular la presión arterial, aliviar dolores artríticos, eliminar tóxicos del organismo, estados de alergias y asma.OBJETIVOS: clasificar el polvo del fruto seco de M. citrifolia NONI-C® según el método de las clases de toxicidad aguda (CTA). MÉTODOS: se evaluó el NONI-C® mediante el ensayo de las clases de toxicidad, que permite clasificar la sustancia en un rango de toxicidad. Se utilizaron 6 hembras de la sublínea Cenp:SPRD, procedentes del Centro Nacional para la Producción de Animales de Laboratorio (CENPALAB). Se les administró una dosis única de 2 g de material vegetal seco/kg de peso corporal de NONI-C® por vía oral, previo ayuno. El período de observación fue de 14 d, en el cual se monitorearon las condiciones ambientales diariamente, la aparición de signos de toxicidad y muerte, así como el peso corporal en los días 0, 7 y 14 del ensayo. RESULTADOS: los animales alcanzaron 100 % de supervivencia. No se observaron signos de toxicidad, tras la administración de la sustancia ensayo en la dosis máxima de 2 g/kg. En la evaluación anatomopatológica no se observaron alteraciones macroscópicas en la superficie externa de los animales y en ninguna de sus cavidades, órganos y tejidos. CONCLUSIONES: de acuerdo con el método de toxicidad de clases, el producto NONI-C® resultó no clasificado, DL50 aguda es mayor que 2 g/kg.

INTRODUCTION: Morinda citrifolia L. has been used in the traditional medicine to reduce the chronic pains, to regulate the blood pressure, to relieve arthritic pains, to eliminate the toxic agents of organism, allergy states and asthma. OBJECTIVES: to classify the dry fruit powder of M. citrifolia NONI-C®according the different acute toxicity kinds. METHODS: we used 6 female rats of Cenp:SPRD subspecies from The National Center for the Production of Laboratory Animals (NCPLA). A 2 g single dose of dry vegetal material/kg of body weight of NONI-C® was administered per os before breakfast. Observation period was of 14 days to monitoring the daily environmental conditions, appearance of toxicity signs, and death, as well as the body weight at 0, 7 and 14 days from assay. RESULTS: animals had a 100 % survival. There were not toxicity signs after assayed substance administration it maximal 2 g/kg dose. In anatomical and pathological evaluation there were neither macroscopic alterations in external surface of animals nor in its cavities, organs and tissues. CONCLUSIONS: accordint to toxicity kinds method, NONI-C® was not classified, acute DL50 is higher than 2 g/kg.

Hepatotoxicity and subchronic toxicity tests of Morinda citrifolia (noni) fruit.

Morinda citrifolia (noni) fruit juice has been approved as a safe food in many nations. A few cases of hepatitis in people who had been drinking noni juice have been reported, even though no causal link could be established between the liver injury and ingestion of the juice. To more fully evaluate the hepatotoxic potential of noni fruit juice, in vitro hepatotoxicity tests were conducted in human liver cells, HepG2 cell line. A subchronic oral toxicity test of noni fruit was also performed in Sprague-Dawley (SD) rats to provide benchmark data for understanding the safety of noni juice, without the potential confounding variables associated with many commercial noni juice products. Freeze-dried filtered noni fruit puree did not decrease HepG2 cell viability or induce neutral lipid accumulation and phospholipidosis. There were no histopathological changes or evidence of dose-responses in hematological and clinical chemistry measurements, including liver function tests. The no-observed-adverse-effect level (NOAEL) for freeze-dried noni fruit puree is greater than 6.86 g/kg body weight, equivalent to approximately 90 ml of noni fruit juice/kg. These findings corroborate previous conclusions that consumption of noni fruit juice is unlikely to induce adverse liver effects.

Prenatal toxicity test of Morinda citrifolia (noni) fruit.

Morinda citrifolia (noni) fruit juice use has increased greatly within the past decade, with more than 80,000,000 liters being consumed world wide. With increasing widespread use and the potential use among pregnant women, a prenatal developmental toxicity test was conducted to further evaluate the safety of noni juice. Freeze-dried noni fruit puree from French Polynesia was administered daily by gastric intubation to separate dose groups (n = 12) of pregnant Sprague Dawley rats at 1.72, 3.43, and 6.86 g/kg body weight, with a control group receiving water in place of noni. The dose schedule was followed from the first day of gestation until one day prior to expected delivery, 21 days. There were no symptoms of toxicity in the pregnant dams. There was no difference between the control and any noni group in the number of live fetuses, resorptions, fetal weight and length, or skeletal abnormalities. No dead fetuses, gross external malformations, or internal organ defects were observed in any group. These findings do not indicate that toxicity from noni juice to developing embryos and fetuses is expected.

El zumo de Tahitian Noni® no es hepatotóxico / No disponible

No disponible

Réplica. El zumo de Tahitian Noni® no es hepatotóxico: nuestros comentarios / No disponible

No disponible